These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 6857692)

  • 1. Toxicological evaluation of poison oak urushiol and its esterified derivative.
    Murphy JC; Watson ES; Harland EC
    Toxicology; 1983 Feb; 26(2):135-42. PubMed ID: 6857692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunologic studies of poisonous Anacardiaceae: oral desensitization to poison ivy and oak urushiols in guinea pigs.
    Watson ES; Murphy JC; ElSohly MA
    J Invest Dermatol; 1983 Mar; 80(3):149-55. PubMed ID: 6219167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunologic studies of poisonous Anacardiaceae: I. Production of tolerance and desensitization to poison Ivy and oak urushiols using esterified urushiol derivatives in guinea pigs.
    Watson ES; Murphy JC; Wirth PW; Waller CW; Elsohly MA
    J Invest Dermatol; 1981 Mar; 76(3):164-70. PubMed ID: 6453903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single dose parenteral hyposensitization to poison ivy urushiol in guinea pigs.
    Walker LA; Watson ES; elSohly MA
    Immunopharmacol Immunotoxicol; 1995 Aug; 17(3):565-76. PubMed ID: 8576546
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro studies of poison oak immunity. II. Effect of urushiol analogues on the human in vitro response.
    Byers VS; Castagnoli N; Epstein WL
    J Clin Invest; 1979 Nov; 64(5):1449-56. PubMed ID: 315415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of the contact sensitivity response to urushiol with anti-urushiol monoclonal antibody ALG 991.
    Baldwin RW; Clegg JA; Curran AC; Austin EB; Khan T; Ma Y; Gunn B; Hudecz F; Byers VS; Lepoittevin JP; Price MR
    Arch Dermatol Res; 1999 Dec; 291(12):652-8. PubMed ID: 10651166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Poison oak hyposensitization. Evaluation of purified urushiol.
    Epstein WL; Baer H; Dawson CR; Khurana RG
    Arch Dermatol; 1974 Mar; 109(3):356-60. PubMed ID: 4273614
    [No Abstract]   [Full Text] [Related]  

  • 8. In vitro studies of poison oak immunity. I. In vitro reaction of human lymphocytes to urushiol.
    Byers VS; Epstein WL; Castagnoli N; Baer H
    J Clin Invest; 1979 Nov; 64(5):1437-48. PubMed ID: 315414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GLC analysis of poison ivy and poison oak urushiol components in vegetable oil preparations.
    Elsohly MA; Turner CE
    J Pharm Sci; 1980 May; 69(5):587-9. PubMed ID: 7381750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of tolerance to poison ivy urushiol in the guinea pig by epicutaneous application of the structural analog 5-methyl-3-n-pentadecylcatechol.
    Stampf JL; Benezra C; Byers V; Castagnoli N
    J Invest Dermatol; 1986 May; 86(5):535-8. PubMed ID: 2943824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urushiol detection using a profluorescent nitroxide.
    Braslau R; Rivera F; Lilie E; Cottman M
    J Org Chem; 2013 Jan; 78(2):238-45. PubMed ID: 22900824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral hyposensitization to poison ivy and poison oak.
    Marks JG; Trautlein JJ; Epstein WL; Laws DM; Sicard GR
    Arch Dermatol; 1987 Apr; 123(4):476-8. PubMed ID: 2950827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allergic contact dermatitis caused by Lithraea molleoides and Lithraea brasiliensis: identification and characterization of the responsible allergens.
    Alé SI; Ferreira F; González G; Epstein W
    Am J Contact Dermat; 1997 Sep; 8(3):144-9. PubMed ID: 9249282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral and epicutaneous desensitization in urushiol contact dermatitis in guinea pigs sensitized by 2 methods of different sensitizing potency.
    Ikeda Y; Yasuno H; Sato A; Kawai K
    Contact Dermatitis; 1998 Dec; 39(6):286-92. PubMed ID: 9874019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative structure-activity relationships for skin sensitization potential of urushiol analogues.
    Roberts DW; Benezra C
    Contact Dermatitis; 1993 Aug; 29(2):78-83. PubMed ID: 8365181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regiospecific attack of nitrogen and sulfur nucleophiles on quinones derived from poison oak/ivy catechols (urushiols) and analogues as models for urushiol-protein conjugate formation.
    Liberato DJ; Byers VS; Dennick RG; Castagnoli N
    J Med Chem; 1981 Jan; 24(1):28-33. PubMed ID: 7205871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analogues of poison ivy urushiol. Synthesis and biological activity of disubstituted n-alkylbenzenes.
    ElSohly MA; Adawadkar PD; Benigni DA; Watson ES; Little TL
    J Med Chem; 1986 May; 29(5):606-11. PubMed ID: 2939241
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atmospheric pressure ionization LC-MS-MS determination of urushiol congeners.
    Draper WM; Wijekoon D; McKinney M; Behniwal P; Perera SK; Flessel CP
    J Agric Food Chem; 2002 Mar; 50(7):1852-8. PubMed ID: 11902923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies on poison ivy. In vitro lymphocyte transformation by urushiol-protein conjugates.
    Dupuis G
    Br J Dermatol; 1979 Dec; 101(6):617-24. PubMed ID: 161173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Final report on the safety assessment of capsicum annuum extract, capsicum annuum fruit extract, capsicum annuum resin, capsicum annuum fruit powder, capsicum frutescens fruit, capsicum frutescens fruit extract, capsicum frutescens resin, and capsaicin.
    Int J Toxicol; 2007; 26 Suppl 1():3-106. PubMed ID: 17365137
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.